Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
69,31-07-2022,SANTA MARIA ,61 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | TID |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,31-07-2022,31-07-2022,,,85,OPD,
175,30-07-2022,KASOA - OPEIKUMA BLUE KIOSK,69 Year(s),Male,,,,No Outcome,NA ,E08.11 [Diabetes mellitus due to underlying condition with ketoacidosis with coma]  ==> NEW,,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",,,30-07-2022,30-07-2022,,,0,OPD,
286,29-07-2022,SOWUTOUM-AU AKU,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,29-07-2022,29-07-2022,,,10,OPD,24171/18
321,29-07-2022,upper weija,51 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",TRADER,,29-07-2022,29-07-2022,,,20,OPD,
633,29-07-2022,"KASOA
OFANKOR",39 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 5 Days  ]",,fire officer,,29-07-2022,29-07-2022,,,50,OPD,
712,28-07-2022,weija,60 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,"S60.412A [Abrasion of right middle finger, initial encounter]  ==> NEW, E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD",I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule | TID |  For 5 Days  ], ANTI TETANUS SERUM1500IU[ ATS | 1500IU/ML | Injection | Stat |  For 1 Days  ], DICLOFENAC TABLET 100MG[ LOFNAC | 100MG | Tablet | OD |  For 3 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 85 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,28-07-2022,28-07-2022,,,20,OPD,
728,28-07-2022,ABLEKUMA,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,J00. [Acute nasopharyngitis [common cold]]  ==> NEW,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | Nocte |  For 3 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ]",TRADER,,28-07-2022,28-07-2022,,,10,OPD,
730,28-07-2022,CHOICE,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, R68.83 [Chills (without fever)]  ==> NEW",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",Unemployed,,28-07-2022,28-07-2022,,,10,OPD,
732,28-07-2022,GBAWE-BULEMI,66 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",PASTOR,,28-07-2022,28-07-2022,,,20,OPD,19702/20
733,28-07-2022,GBAWE-BULEMI,83 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,28-07-2022,28-07-2022,,,60,OPD,4397/20
734,28-07-2022,WEIJA-CHOICE,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",TRADER,,28-07-2022,28-07-2022,,,10,OPD,30374/17 MR-1A-F4-33
764,28-07-2022,TETEGU,52 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,,,,,28-07-2022,28-07-2022,,,10,OPD,
767,28-07-2022,BORTIANOR ,54 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,28-07-2022,28-07-2022,,,10,OPD,
788,28-07-2022,KASOA. NEW TOWN,69 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, Z87.11 [Personal history of peptic ulcer disease]  ==> NEW",No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], SUCRAFIL- O SUSPENSION[ SUCRAFIL- O   | 100ML | Suspension | TID |  For 7 Days  ]",,,,28-07-2022,28-07-2022,,,10,OPD,
903,28-07-2022,KASOA,42 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,,,,,28-07-2022,28-07-2022,,,10,OPD,
923,28-07-2022,ablekuma pentecost junction,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,28-07-2022,28-07-2022,,,20,OPD,
940,28-07-2022,"AGAPE
PENTECOST",75 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,28-07-2022,28-07-2022,,,10,OPD,
1004,28-07-2022,KASOA ROAD,70 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,28-07-2022,28-07-2022,,,10,OPD,
1025,28-07-2022,GBAWE-BULEMI,50 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M19.91 [Primary osteoarthritis, unspecified site]  ==> NEW",No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 0 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 0 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Nocte |  For 90 Days  ], DREZ OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | TDS |  For 5 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], DREZ OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",caterer,,28-07-2022,28-07-2022,,,20,OPD,20499/19
1029,28-07-2022,GBAWE,46 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ]",,,,28-07-2022,28-07-2022,,,10,OPD,
1191,28-07-2022,tetegu,51 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],,,,28-07-2022,28-07-2022,,,10,OPD,
1364,27-07-2022,kokorbitey,35 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",BUSINESS PERSON,,27-07-2022,27-07-2022,,,20,OPD,
1393,27-07-2022,KASOA ,58 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,A02.25 [Salmonella pyelonephritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture | TDS |  For 7 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,27-07-2022,27-07-2022,,,10,OPD,
1433,27-07-2022,MADINA,48 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> NEW, K85.01 [Idiopathic acute pancreatitis with uninfected necrosis]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW, B37.49 [Other urogenital candidiasis]  ==> NEW, K29.30 [Chronic superficial gastritis without bleeding]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | Daily |  For 1 Days  ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet | Nocte |  For 6 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ]",,,,27-07-2022,27-07-2022,,,10,OPD,
1434,27-07-2022,ABLEKUMA,32 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,Z86.32 [Personal history of gestational diabetes]  ==> NEW,,No,Insured,,,Teacher,,27-07-2022,27-07-2022,,,0,OPD,
1441,27-07-2022,teteku miame,41 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> NEW",,Yes,Insured,,,TRADER,,27-07-2022,27-07-2022,,,0,OPD,
1603,27-07-2022,SANTA MARIA,48 Year(s),Male,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E08.311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> NEW,E08.36 [Diabetes mellitus due to underlying condition with diabetic cataract]  ==> NEW,No,Insured,,,TRADER,,27-07-2022,27-07-2022,,,10,OPD,
1668,27-07-2022,kasao,58 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,27-07-2022,27-07-2022,,,20,OPD,
1840,27-07-2022,"NEW BORTIANOR , KASSAPA ",52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K25.3 [Gastric ulcer: Acute without haemorrhage or perforation]  ==> NEW, A01.09 [Typhoid fever with other complications]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",TRADER,,27-07-2022,27-07-2022,,,10,OPD,
1902,27-07-2022,KORLE GONNO,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.01 [Diabetes mellitus due to underlying condition with hyperosmolarity with coma]  ==> NEW,"G93.2 [Benign intracranial hypertension]  ==> NEW, A02.1 [Salmonella sepsis]  ==> NEW",No,Insured,"AMOXICILIN+CLAVULANIC ACID INJECTION 1.2G[ AMOKSICLAV | 1.2G | Injection | Stat |  For 1 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BDS |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC TABLET 100MG[ LOFNAC | 100MG | Tablet | BDS |  For 5 Days  ]","AMOXICILIN+CLAVULANIC ACID INJECTION 1.2G[ AMOKSICLAV | 1.2G | Injection ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], DICLOFENAC TABLET 100MG[ LOFNAC | 100MG | Tablet ]",,,27-07-2022,27-07-2022,,,10,OPD,
1936,27-07-2022,OPEIKUMA,69 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"J45.30 [Mild persistent asthma, uncomplicated]  ==> NEW",No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SALBUTAMOL NEBULES 2.5MG[ SALBUTAMOL | 2.5MG | Nebules | TID |  For 1 Days  ], HYDROCORTISONE INJECTION 100MG[ HYDROCORTISONE | 100MG | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SALBUTAMOL NEBULES 2.5MG[ SALBUTAMOL | 2.5MG | Nebules ], HYDROCORTISONE INJECTION 100MG[ HYDROCORTISONE | 100MG | Injection ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,27-07-2022,27-07-2022,,,85,OPD,
1946,27-07-2022,WEIJA,58 Year(s),Female,,,,No Outcome,NA ,E10.649 [Type 1 diabetes mellitus with hypoglycemia without coma]  ==> NEW,,No,Non-Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | TDS |  For 7 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Daily |  For 2 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | q6h |  For 1 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ]",Unemployed,,27-07-2022,27-07-2022,,,94,OPD,
1950,26-07-2022,weija,62 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M19.91 [Primary osteoarthritis, unspecified site]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
1952,26-07-2022,WEIJA- CHOICE,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
1957,26-07-2022,ablekuman,53 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,26-07-2022,26-07-2022,,,20,OPD,
1959,26-07-2022,WEIJA TOPBASE,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID w/meals |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,26-07-2022,26-07-2022,,,20,OPD,
1962,26-07-2022,"TUBA , IIRGATION FARMS",54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,26-07-2022,26-07-2022,,,20,OPD,
1966,26-07-2022,Broadcasing ,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,26-07-2022,26-07-2022,,,20,OPD,
1967,26-07-2022,santa maria,89 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M19.91 [Primary osteoarthritis, unspecified site]  ==> OLD",No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",,,26-07-2022,26-07-2022,,,20,OPD,
1968,26-07-2022,dansoman Ebeneezer down,42 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
1970,26-07-2022,APLAKU,68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
2004,26-07-2022,SCC,61 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"K37. [Unspecified appendicitis]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
2013,26-07-2022,"ODORKOR
ST ANTHONY",76 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K29.20 [Alcoholic gastritis without bleeding]  ==> NEW, E16.9 [Disorder of pancreatic internal secretion, unspecified]  ==> NEW, A01.09 [Typhoid fever with other complications]  ==> OLD",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
2021,26-07-2022,TUBA. BEECH DRIVE ESTATE.,61 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 10 Days  ]","AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
2033,26-07-2022,SCC,33 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Insured,"DROTAVERINE TABLET (NOSPA )40MG)[ NOSPA | 40MG | Tablet | BID |  For 5 Days  ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | BID |  For 1 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BID |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","DROTAVERINE TABLET (NOSPA )40MG)[ NOSPA | 40MG | Tablet ], CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
2068,26-07-2022,SOWUTUOM ,70 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,R06.6 [Hiccough]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METOCLOPRAMIDE TABLET 10MG[ METOCLOPRAMIDE | 10MG | Tablet | TID |  For 7 Days  ]",,Para Professional,,26-07-2022,26-07-2022,,,50,OPD,
2093,26-07-2022,AWOSHIE,44 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,26-07-2022,26-07-2022,,,20,OPD,
2120,26-07-2022,new weija azumah,65 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,M35.3 [Polymyalgia rheumatica]  ==> NEW,No,Insured,"BRIDELIA TEA[ HERBAL |  | Powder | BDS |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 7 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | TID |  For 14 Days  ]",,,,26-07-2022,26-07-2022,,,10,OPD,
2136,26-07-2022,WEJIA,72 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,26-07-2022,26-07-2022,,,10,OPD,
2162,26-07-2022,"BUBUASHIE , ATIKO ",57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,R07.0 [Pain in throat]  ==> NEW,No,Insured,"ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]",,TRADER,,26-07-2022,26-07-2022,,,10,OPD,
2242,26-07-2022,KASOA ADOM CITY,87 Year(s),Male,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,B35.3 [Tinea pedis]  ==> OLD,No,Insured,"DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 7 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | Stat |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]","DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,26-07-2022,26-07-2022,,,10,OPD,
2337,26-07-2022,SEMANSHIA,72 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.01 [Diabetes mellitus due to underlying condition with hyperosmolarity with coma]  ==> NEW,,No,Insured,,,,,26-07-2022,26-07-2022,,,10,OPD,
2355,26-07-2022,MILE 11. FINI HOSPITAL,62 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet | Nocte |  For 10 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream | TDS |  For 10 Days  ], Polygynax (pessaries)[  |  | Pessary | Nocte |  For 7 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream ], Polygynax (pessaries)[  |  | Pessary ]",,,26-07-2022,26-07-2022,,,20,OPD,
2591,25-07-2022,new bortianor,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,25-07-2022,25-07-2022,,,10,OPD,
2595,25-07-2022,ABLEKUMAN,61 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,25-07-2022,25-07-2022,,,20,OPD,
2596,25-07-2022,NEW GBAWE,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ]","FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",,,25-07-2022,25-07-2022,,,10,OPD,
2597,25-07-2022,awoshie,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 90 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,25-07-2022,25-07-2022,,,10,OPD,
2598,25-07-2022,kasoa,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,25-07-2022,25-07-2022,,,10,OPD,
2600,25-07-2022,DANSOMAN,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,25-07-2022,25-07-2022,,,20,OPD,
2601,25-07-2022,behind westhills mall,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet ]",,,25-07-2022,25-07-2022,,,20,OPD,
2603,25-07-2022,kasoa,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,25-07-2022,25-07-2022,,,20,OPD,
2646,25-07-2022,TANTRA HILLS ,74 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,25-07-2022,25-07-2022,,,10,OPD,
2653,25-07-2022,TUBA ,69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,25-07-2022,25-07-2022,,,10,OPD,
2681,25-07-2022,MALLAM,33 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,"O24.410 [Gestational diabetes mellitus in pregnancy, diet controlled]  ==> NEW",,No,Insured,,,TRADER,,25-07-2022,25-07-2022,,,0,OPD,
2700,25-07-2022,BORTIANOR-PENTECOST,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 14 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BID |  For 14 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,25-07-2022,25-07-2022,,,50,OPD,
2723,25-07-2022,new bortianor,71 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,25-07-2022,25-07-2022,,,0,OPD,
2747,25-07-2022,mallam bola road,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,25-07-2022,25-07-2022,,,10,OPD,
2899,25-07-2022,JOHN TEYE,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"J01.10 [Acute frontal sinusitis, unspecified]  ==> NEW",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 14 Days  ]",,,,25-07-2022,25-07-2022,,,10,OPD,
2926,25-07-2022,"NEW GBAWE , TIME SPOT",53 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,25-07-2022,25-07-2022,,,20,OPD,
3120,25-07-2022,JAMES TOWN ACCRA,78 Year(s),Female,,,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Unemployed,,25-07-2022,25-07-2022,,,10,OPD,
3464,23-07-2022,MACCATHY,71 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 2 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | BDS |  For 1 Days  ], AZITHROMYCIN CAPSULE 250MG[ AZITHROMYCIN | 250MG | Tablet | Daily |  For 3 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]",,RETIER,,23-07-2022,23-07-2022,,,10,OPD,
3503,22-07-2022,weija,71 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,No,Insured,"ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], MULTIVITAMIN TABLET[ MULTIVITAMIN |  | Tablet | Daily |  For 90 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]","ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], MULTIVITAMIN TABLET[ MULTIVITAMIN |  | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,22-07-2022,22-07-2022,,,10,OPD,
3504,22-07-2022,kasoa,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,22-07-2022,22-07-2022,,,20,OPD,
3547,22-07-2022,"ODORKOR
ST ANTHONY",76 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,22-07-2022,22-07-2022,,,10,OPD,
3557,22-07-2022,sowutuom,47 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 10 Days  ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ]",,,,22-07-2022,22-07-2022,,,10,OPD,
3572,22-07-2022,GBAWE TELECOM,50 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,22-07-2022,22-07-2022,,,10,OPD,
3574,22-07-2022,"KASOA
OPEIKUMA",56 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ]",,,,22-07-2022,22-07-2022,,,0,OPD,
3578,22-07-2022,NEW BORTIANOR,71 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, G20. [Parkinson disease]  ==> NEW, I64. [Stroke, not specified as haemorrhage or infarction]  ==> NEW",No,Insured,,,,,22-07-2022,22-07-2022,,,10,OPD,
3659,22-07-2022,kwashieman,47 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,22-07-2022,22-07-2022,,,0,OPD,
3672,22-07-2022,PALAS TOWN ANYAA,67 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, I20.9 [Angina pectoris, unspecified]  ==> NEW",No,Insured,,,,,22-07-2022,22-07-2022,,,10,OPD,
3942,21-07-2022,pokuase white house,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, Z86.31 [Personal history of diabetic foot ulcer]  ==> NEW",No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | BID |  For 10 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TDS |  For 5 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet | PRN |  For 5 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet ]",unemploed,,21-07-2022,21-07-2022,,,10,OPD,
3944,21-07-2022,mc carthy,79 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M19.91 [Primary osteoarthritis, unspecified site]  ==> NEW",No,Insured,"BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]",,,,21-07-2022,21-07-2022,,,20,OPD,
3945,21-07-2022,awoshie,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]",,,,21-07-2022,21-07-2022,,,10,OPD,
3946,21-07-2022,ABLEKUIMA ,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M19.91 [Primary osteoarthritis, unspecified site]  ==> NEW",No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 90 Days  ], PARACETAMOL SUPPOSITORY 1G[ PARACETAMOL | 1G | Suppository | PRN |  For 5 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], PARACETAMOL SUPPOSITORY 1G[ PARACETAMOL | 1G | Suppository ]",,,21-07-2022,21-07-2022,,,20,OPD,
3947,21-07-2022,,20 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],,,21-07-2022,21-07-2022,,,20,OPD,
3949,21-07-2022,dansoman,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"Z86.31 [Personal history of diabetic foot ulcer]  ==> NEW, N34.2 [Other urethritis]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BID |  For 5 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution ]",,,21-07-2022,21-07-2022,,,10,OPD,
3951,21-07-2022,TUBA. BEECH DRIVE ESTATE.,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,,,,,21-07-2022,21-07-2022,,,20,OPD,
3960,21-07-2022,"KASOA , KULABULE",81 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"M35.3 [Polymyalgia rheumatica]  ==> OLD, G58.9 [Mononeuropathy, unspecified]  ==> NEW",No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup | TID |  For 7 Days  ]",,TRADER,,21-07-2022,21-07-2022,,,10,OPD,
3977,21-07-2022,UPPER WEIJA ,51 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",seamstress,,21-07-2022,21-07-2022,,,10,OPD,
4033,21-07-2022,"GBAWE , SOLID ROCK",72 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I67.9 [Cerebrovascular disease, unspecified]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Non-Insured,,,,,21-07-2022,21-07-2022,,,50,OPD,
4071,21-07-2022,"KASOA , NYANYANO ",84 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, B35.1 [Tinea unguium]  ==> NEW",No,Insured,"NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Daily |  For 5 Days  ], FLUCONAZOLE CAPSULE 200MG[ FLUCONAZOLE | 200MG | Capsule | Daily |  For 5 Days  ]","NAT B CAPSULES[ NAT B |  | Capsule ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ], FLUCONAZOLE CAPSULE 200MG[ FLUCONAZOLE | 200MG | Capsule ]",,,21-07-2022,21-07-2022,,,20,OPD,1663/17 MR-6B-E6-38
4125,21-07-2022,MCCARTHY HILL,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,21-07-2022,21-07-2022,,,20,OPD,
4155,21-07-2022,ODORKOR,51 Year(s),Female,,,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,M79.7 [Fibromyalgia]  ==> NEW,No,Non-Insured,,,TRADER,,21-07-2022,21-07-2022,,,50,OPD,
4160,21-07-2022,ODORKOR,42 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> OLD, M35.3 [Polymyalgia rheumatica]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",TRADER,,21-07-2022,21-07-2022,,,10,OPD,
4172,21-07-2022,kasoa,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ]",,,,21-07-2022,21-07-2022,,,10,OPD,
4177,21-07-2022,"kasoa
top hill",81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PARACETAMOL SUPPOSITORY 500MG[ PARACETAMOL | 500MG | Suppository | PRN |  For 10 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PARACETAMOL SUPPOSITORY 500MG[ PARACETAMOL | 500MG | Suppository ]",,,21-07-2022,21-07-2022,,,10,OPD,
4211,21-07-2022,TETEGU,60 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW",No,Insured,"CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 7 Days  ]","CEFUROXIME TABLET 250MG[ CEFUROXIME | 250MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ]",,,21-07-2022,21-07-2022,,,20,OPD,44011/19
4232,21-07-2022,"ANYAA
LAST STOP",38 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,,No,Non-Insured,,,TRADER,,21-07-2022,21-07-2022,,,50,OPD,
4383,21-07-2022,new bortianor,76 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, N34.1 [Nonspecific urethritis]  ==> OLD",No,Non-Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 90 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BID |  For 5 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ]",,,21-07-2022,21-07-2022,,,10,OPD,
4439,21-07-2022,TUBA. BEECH DRIVE ESTATE.,61 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Insured,,,,,21-07-2022,21-07-2022,,,10,OPD,
4509,21-07-2022,AWOSHIE,63 Year(s),Female,,,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | OD |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,21-07-2022,21-07-2022,,,0,OPD,
4618,20-07-2022,ablekuma agape down,42 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Stat |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",TRADER,,20-07-2022,20-07-2022,,,60,OPD,
4625,20-07-2022,fertey ,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,20-07-2022,20-07-2022,,,20,OPD,
4694,20-07-2022,ASHIAMAN,64 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,20-07-2022,20-07-2022,,,60,OPD,
4757,20-07-2022,,69 Year(s),Female,GENERAL OPD,Review Consultation Child,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"I10. [Essential (primary) hypertension]  ==> NEW, A01.4 [Paratyphoid fever, unspecified]  ==> OLD",No,Non-Insured,"CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ]","CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,20-07-2022,20-07-2022,,,10,OPD,
4923,20-07-2022,camara,36 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,20-07-2022,20-07-2022,,,20,OPD,
5163,20-07-2022,ODORKOR,42 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | QID |  For 3 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | TDS |  For 2 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | OD |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",TRADER,,20-07-2022,20-07-2022,,,85,OPD,
5195,20-07-2022,KWASHIMAN,42 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E23.2 [Diabetes insipidus]  ==> NEW,,No,Non-Insured,PROMETHAZINE HYDROCHLORIDE  TABLET 25MG[ PROMETHAZINE | 25MG | Tablet | Nocte |  For 5 Days  ],,CONTRACTOR,,20-07-2022,20-07-2022,,,50,OPD,
5213,20-07-2022,"AGLO FARMS -
TUBA ",49 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"B37.3 [Candidiasis of vulva and vagina]  ==> NEW, N75.0 [Cyst of Bartholin gland]  ==> NEW",No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | QID |  For 1 Days  ], MICONAZOLE OVULE 40OMG[ MICONAZOLE PESS | 400MG | Ovule | Nocte |  For 3 Days  ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BID |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], MICONAZOLE OVULE 40OMG[ MICONAZOLE PESS | 400MG | Ovule ], DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ]",PASTOR,,20-07-2022,20-07-2022,,,105,OPD,
5304,19-07-2022,kasoa,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K02.8 [Other dental caries]  ==> NEW",No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,19-07-2022,19-07-2022,,,20,OPD,
5307,19-07-2022,"kasoa 
iron city",68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,19-07-2022,19-07-2022,,,20,OPD,
5313,19-07-2022,apleku,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,19-07-2022,19-07-2022,,,10,OPD,
5326,19-07-2022,mallam bola road ,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,19-07-2022,19-07-2022,,,10,OPD,
5327,19-07-2022,agape down,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet | Nocte |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet ]",,,19-07-2022,19-07-2022,,,10,OPD,
5328,19-07-2022,gbawe zero,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, I67.89 [Other cerebrovascular disease]  ==> NEW",No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,19-07-2022,19-07-2022,,,20,OPD,
5330,19-07-2022,dankuman,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,19-07-2022,19-07-2022,,,20,OPD,
5393,19-07-2022,santa maria-drug store,56 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,19-07-2022,19-07-2022,,,10,OPD,
5397,19-07-2022,AFRAM PLAINS ,68 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,M35.3 [Polymyalgia rheumatica]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,19-07-2022,19-07-2022,,,10,OPD,
5409,19-07-2022,KASOA TUBA,55 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,19-07-2022,19-07-2022,,,0,OPD,
5434,19-07-2022,TUBA-ADDO MOSQUAE,85 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, B35.4 [Tinea corporis]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ], DIPROSON LOTION[ DIPROSON  | 0.05% 30G | Lotion | BID |  For 10 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet ], DIPROSON LOTION[ DIPROSON  | 0.05% 30G | Lotion ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,19-07-2022,19-07-2022,,,10,OPD,30043/20
5440,19-07-2022,kasoa,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,19-07-2022,19-07-2022,,,0,OPD,
5453,19-07-2022,oblogo,38 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], Polygynax (pessaries)[  |  | Pessary | Nocte |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], Polygynax (pessaries)[  |  | Pessary ]",,,19-07-2022,19-07-2022,,,20,OPD,
5458,19-07-2022,KOKROBITE,56 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUMETHIAZIDE TABLET 5MG[ BENDROFLUMETHIAZIDE | 5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",unemploed,,19-07-2022,19-07-2022,,,10,OPD,
5465,19-07-2022,MALLAM-JULI CATE,61 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Non-Insured,,,Pensioner,,19-07-2022,19-07-2022,,,50,OPD,
5546,19-07-2022,BARRIER ,65 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | BID |  For 3 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 3 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ]","CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",Retired,,19-07-2022,19-07-2022,,,10,OPD,
5753,19-07-2022,kasoa,66 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,19-07-2022,19-07-2022,,,0,OPD,
5851,19-07-2022,"OLD BARRIER 
SAMPA VALLEY",68 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"J20.9 [Acute bronchitis, unspecified]  ==> NEW",No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ], AZITHROMYCIN CAPSULE 250MG[ AZITHROMYCIN | 250MG | Tablet | Daily |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], AZITHROMYCIN CAPSULE 250MG[ AZITHROMYCIN | 250MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",Pensioner,,19-07-2022,19-07-2022,,,50,OPD,
5876,19-07-2022,SAMPA VALLEY,64 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",,,19-07-2022,19-07-2022,,,50,OPD,
5915,18-07-2022,kasoa,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 7 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], Polygynax (pessaries)[  |  | Pessary | Nocte |  For 7 Days  ], CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream | TID |  For 7 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ]","DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], Polygynax (pessaries)[  |  | Pessary ], CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,18-07-2022,18-07-2022,,,20,OPD,
5926,18-07-2022,kasoa,53 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 0 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,18-07-2022,18-07-2022,,,20,OPD,
5928,18-07-2022,kasoa,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,18-07-2022,18-07-2022,,,20,OPD,
5932,18-07-2022,KWASHIEBU,86 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,18-07-2022,18-07-2022,,,20,OPD,
5933,18-07-2022,mallam ,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",TRADER,,18-07-2022,18-07-2022,,,10,OPD,
6033,18-07-2022,"GBAWE 
TOP BASE ",46 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,,,MOBILE BANKER,,18-07-2022,18-07-2022,,,50,OPD,
6050,18-07-2022,MALLAM MARKET,71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,18-07-2022,18-07-2022,,,20,OPD,
6054,18-07-2022,weija ,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 900 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,18-07-2022,18-07-2022,,,20,OPD,
6207,18-07-2022,tuba,71 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,"E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW, I10. [Essential (primary) hypertension]  ==> OLD",No,Insured,SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | QID |  For 1 Days  ],SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ],,,18-07-2022,18-07-2022,,,20,OPD,
6947,15-07-2022,ODORKOR. GLORYLAND,51 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,15-07-2022,15-07-2022,,,20,OPD,
6952,15-07-2022,NSAKINA,67 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"K40.90 [Unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent]  ==> NEW, I10. [Essential (primary) hypertension]  ==> NEW",No,Non-Insured,"CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | BID |  For 3 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet | OD |  For 30 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | OD |  For 1 Days  ]","CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ]",Unemployed,,15-07-2022,15-07-2022,,,60,OPD,
7027,15-07-2022,GBAWE,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 60 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,15-07-2022,15-07-2022,,,15,OPD,
7035,15-07-2022,AWOSHIE,77 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"L MONTUS ADULT 10MG[ L MONTUS ADULT | 10MG | Tablet | Nocte |  For 10 Days  ], BETNOVATE C CREAM[ BETNOVATE C | 30G | Cream | BDS |  For 14 Days  ], CLINDAMYCIN CAPSULE 150MG[ CLINDAMYCIN | 150MG | Capsule | BDS |  For 7 Days  ]","L MONTUS ADULT 10MG[ L MONTUS ADULT | 10MG | Tablet ], BETNOVATE C CREAM[ BETNOVATE C | 30G | Cream ], CLINDAMYCIN CAPSULE 150MG[ CLINDAMYCIN | 150MG | Capsule ]",,,15-07-2022,15-07-2022,,,10,OPD,
7106,15-07-2022,TETEGU,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, L03.119 [Cellulitis of unspecified part of limb]  ==> NEW",No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BID |  For 90 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 90 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,15-07-2022,15-07-2022,,,10,OPD,
7160,15-07-2022,"BLOCK FACTORY , WEIJA ",30 Year(s),Male,,,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Para Professional,,15-07-2022,15-07-2022,,,0,OPD,
7190,15-07-2022,AWOSHIE  ONYINASE LANE 11,71 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 5 Days  ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], DICLOFENAC INJECTION 75MG[ DICLOFENAC | 75MG/3ML | Injection ]",,,15-07-2022,15-07-2022,,,85,OPD,
7318,14-07-2022,odorkor,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,14-07-2022,14-07-2022,,,20,OPD,
7319,14-07-2022,kasoa,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,14-07-2022,14-07-2022,,,20,OPD,
7320,14-07-2022,aburi,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,14-07-2022,14-07-2022,,,10,OPD,
7324,14-07-2022,UPPER WEIJA,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, F51.01 [Primary insomnia]  ==> NEW",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 60 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 60 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 60 Days  ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet | Nocte |  For 5 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], DIAZEPAM TABLET 5MG[ DIAZEPAM | 5MG | Tablet ]",,,14-07-2022,14-07-2022,,,20,OPD,
7326,14-07-2022,"ABLEKUMA , AGAPE",51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,14-07-2022,14-07-2022,,,10,OPD,
7329,14-07-2022,AWOSHIE ,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K59.09 [Other constipation]  ==> NEW",No,Non-Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup | PRN |  For 10 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup ]",,,14-07-2022,14-07-2022,,,60,OPD,
7330,14-07-2022,gbawe,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,14-07-2022,14-07-2022,,,20,OPD,
7364,14-07-2022,TUBA. BEECH DRIVE ESTATE.,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | Stat |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | TID |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,14-07-2022,14-07-2022,,,15,OPD,
7391,14-07-2022,AMANFRO ,54 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ARTEMETHER+LUMEFANTRINE 20MG+120MG[ ARTEMETHER+LUMEFANTRINE | 20/120MG | Tablet | TID |  For 3 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], TOT-HEMA  SYRUP (IN AMPOULES)[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BDS |  For 10 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | TID |  For 10 Days  ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet | OD |  For 30 Days  ]","ARTEMETHER+LUMEFANTRINE 20MG+120MG[ ARTEMETHER+LUMEFANTRINE | 20/120MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], TOT-HEMA  SYRUP (IN AMPOULES)[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], LISINOPRIL TABLET 5MG[ LISINOPRIL | 5MG | Tablet ]",,,14-07-2022,14-07-2022,,,10,OPD,
7484,14-07-2022,WEIJA,53 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,14-07-2022,14-07-2022,,,50,OPD,
7536,14-07-2022,MALLAM ,46 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,J00. [Acute nasopharyngitis [common cold]]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,14-07-2022,14-07-2022,,,10,OPD,
7546,14-07-2022,MCCARTHY ,86 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Non-Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",Retired,,14-07-2022,14-07-2022,,,50,OPD,
7612,14-07-2022,DARKUMAN ,58 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 15MG[ PIOGLITAZONE | 15MG | Tablet | Daily |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TID |  For 5 Days  ]",,RETRIED,,14-07-2022,14-07-2022,,,20,OPD,
7750,14-07-2022,mallam,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,N34.1 [Nonspecific urethritis]  ==> NEW,No,Insured,"CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | PRN |  For 5 Days  ]","CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ]",,,14-07-2022,14-07-2022,,,10,OPD,
7827,14-07-2022,ABLEKUMA,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, G62.9 [Polyneuropathy, unspecified]  ==> NEW",No,Insured,,,,,14-07-2022,14-07-2022,,,10,OPD,
7946,14-07-2022,"BLOCK FACTORY , WEIJA ",30 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | QID |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",Para Professional,,14-07-2022,14-07-2022,,,85,OPD,
8000,13-07-2022,ablekuman,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"B83.8 [Other specified helminthiases]  ==> NEW, I10. [Essential (primary) hypertension]  ==> OLD",No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | Daily |  For 7 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | Nocte |  For 3 Days  ]","LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ]",,,13-07-2022,13-07-2022,,,20,OPD,
8001,13-07-2022,weija katapilar,39 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ]",,,13-07-2022,13-07-2022,,,20,OPD,
8024,13-07-2022,kasoa,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",,,13-07-2022,13-07-2022,,,30,OPD,
8060,13-07-2022,"BLOCKFACTORY 
SCC",56 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,,,Pensioner,,13-07-2022,13-07-2022,,,10,OPD,
8077,13-07-2022,WEIJA ,52 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.622 [Diabetes mellitus due to underlying condition with other skin ulcer]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,13-07-2022,13-07-2022,,,10,OPD,
8078,13-07-2022,MALLAM-MASALACHI,64 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ]",,,,13-07-2022,13-07-2022,,,10,OPD,
8088,13-07-2022,KASOA,55 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,13-07-2022,13-07-2022,,,10,OPD,MR-7A-F5-118
8171,13-07-2022,gbawe,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TID |  For 5 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | Daily |  For 30 Days  ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ]",,,13-07-2022,13-07-2022,,,20,OPD,
8238,13-07-2022,KASOA,49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,,,13-07-2022,13-07-2022,,,10,OPD,
8350,13-07-2022,SANTA MARIA ,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,13-07-2022,13-07-2022,,,20,OPD,
8398,13-07-2022,kasao,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Non-Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,13-07-2022,13-07-2022,,,20,OPD,
8718,12-07-2022,joeman,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, D05.7 [Other carcinoma in situ of breast]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | Daily |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ]",,,12-07-2022,12-07-2022,,,20,OPD,
8723,12-07-2022,KWASHIMAN,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> NEW,"L60.1 [Onycholysis]  ==> NEW, R73.9 [Hyperglycaemia, unspecified]  ==> NEW, B36.9 [Superficial mycosis, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | Stat |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], ITRACONAZOLE CAPSULE 100MG[ ITRACONAZOLE | 100MG | Capsule | BID |  For 14 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], ITRACONAZOLE CAPSULE 100MG[ ITRACONAZOLE | 100MG | Capsule ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",,,12-07-2022,12-07-2022,,,20,OPD,
8725,12-07-2022,FADAMA,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,12-07-2022,12-07-2022,,,20,OPD,
8727,12-07-2022,tetegu,45 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]",,BUSINESS PERSON,,12-07-2022,12-07-2022,,,20,OPD,
8787,12-07-2022,KWASHIEMAN,57 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,K29.30 [Chronic superficial gastritis without bleeding]  ==> NEW,No,Insured,,,,,12-07-2022,12-07-2022,,,10,OPD,
8789,12-07-2022,SANTA MARIA ,76 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, I64. [Stroke, not specified as haemorrhage or infarction]  ==> NEW, N77.01 [Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere]  ==> NEW",No,Insured,,,,,12-07-2022,12-07-2022,,,10,OPD,
8817,12-07-2022,ABEKWASE ,77 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"K29.40 [Chronic atrophic gastritis without bleeding]  ==> OLD, D46.4 [Refractory anaemia, unspecified]  ==> NEW, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, A01.09 [Typhoid fever with other complications]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet | BID |  For 14 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",pension,,12-07-2022,12-07-2022,,,10,OPD,
8820,12-07-2022,KASOA,43 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,12-07-2022,12-07-2022,,,10,OPD,
8824,12-07-2022,AWOSHIE  ONYINASE LANE 11,71 Year(s),Female,,,,No Outcome,NA ,E10.65 [Type 1 diabetes mellitus with hyperglycemia]  ==> NEW,"A01.09 [Typhoid fever with other complications]  ==> NEW, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW",No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder | BDS |  For 3 Days  ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule | TDS |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 14 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 21 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], ORAL REHYDRATION SALTS [  O.R.S. | 25G | Powder ], AMOXICILLIN CAPSULE 500MG[ AMOXICILIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ]",,,12-07-2022,12-07-2022,,,0,OPD,
8874,12-07-2022,NEW WEIJA,72 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet | Daily |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,12-07-2022,12-07-2022,,,10,OPD,
8879,12-07-2022,ABLEKUMA,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 1 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | q6h |  For 7 Days  ]","NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ]",,,12-07-2022,12-07-2022,,,10,OPD,
9173,12-07-2022,mantaheko,54 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ]",,,,12-07-2022,12-07-2022,,,10,OPD,
9208,12-07-2022,"GBAWE , TELECOM",70 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 5 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",,,12-07-2022,12-07-2022,,,20,OPD,
9230,12-07-2022,SIFOSU,67 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K29.30 [Chronic superficial gastritis without bleeding]  ==> OLD, E16.9 [Disorder of pancreatic internal secretion, unspecified]  ==> NEW",No,Non-Insured,,,,,12-07-2022,12-07-2022,,,50,OPD,
9236,12-07-2022,gbawe,68 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,12-07-2022,12-07-2022,,,0,OPD,
9242,12-07-2022,ASSIN FOSO,69 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,,,Pensioner,,12-07-2022,12-07-2022,,,50,OPD,
9501,12-07-2022,KWASHIMAN,43 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | BDS |  For 1 Days  ],SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ],,,12-07-2022,12-07-2022,,,85,OPD,
9671,11-07-2022,TEMA,43 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,"A01.4 [Paratyphoid fever, unspecified]  ==> NEW",No,Non-Insured,"RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BDS |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TID |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ]","RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",TRADER,,11-07-2022,11-07-2022,,,170,OPD,
9822,09-07-2022,AWOSHIE  ONYINASE LANE 11,71 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule | QID |  For 7 Days  ], DREZ OINTMENT 10G[ DREZ OINTMENT | 10G | Ointment | BID |  For 5 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule ], DREZ OINTMENT 10G[ DREZ OINTMENT | 10G | Ointment ]",,,09-07-2022,09-07-2022,,,10,OPD,
9961,08-07-2022,"WEIJA
MANDELA",49 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E10.9 [Insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | Stat |  For 90 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,08-07-2022,08-07-2022,,,10,OPD,
10004,08-07-2022,sowutuom,47 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | OD |  For 1 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 10 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ]",,,,08-07-2022,08-07-2022,,,0,OPD,
10042,08-07-2022,KWASHIEMAN NAADU SHEET,60 Year(s),Male,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,,,TRADER,,08-07-2022,08-07-2022,,,10,OPD,
10051,08-07-2022,mccarthy ,66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, A09.0 [Other and unspecified gastroenteritis and colitis of infectious origin]  ==> NEW",No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BID |  For 5 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",,,08-07-2022,08-07-2022,,,20,OPD,
10136,08-07-2022,kokorbitey,35 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",BUSINESS PERSON,,08-07-2022,08-07-2022,,,0,OPD,
10422,07-07-2022,KANESHIE,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,07-07-2022,07-07-2022,,,10,OPD,
10435,07-07-2022,kasoa,59 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,07-07-2022,07-07-2022,,,20,OPD,
10438,07-07-2022,WEIJA JUNCTION,57 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,07-07-2022,07-07-2022,,,10,OPD,
10469,07-07-2022,MALLAM ,73 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,07-07-2022,07-07-2022,,,10,OPD,
10533,07-07-2022,KASOA,55 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,,,,,07-07-2022,07-07-2022,,,10,OPD,MR-7A-F5-118
10565,07-07-2022,amanfo,33 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,07-07-2022,07-07-2022,,,10,OPD,
10624,07-07-2022,GBAWE,65 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,07-07-2022,07-07-2022,,,10,OPD,
10625,07-07-2022,AWOSHIE,67 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW, M54.40 [Lumbago with sciatica, unspecified side]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BDS |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,07-07-2022,07-07-2022,,,10,OPD,
10640,07-07-2022,AWOSIHE,49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,TRADER,,07-07-2022,07-07-2022,,,10,OPD,
10652,07-07-2022,ABLEKUMAH-AGAPE,56 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 60 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 60 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | Daily |  For 60 Days  ]",,,,07-07-2022,07-07-2022,,,20,OPD,MR-10A-G5-230
10759,07-07-2022,agape down,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,07-07-2022,07-07-2022,,,20,OPD,
10779,07-07-2022,ACCRA KASOA SCC,65 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,R41.3 [Other amnesia]  ==> NEW,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 14 Days  ],,,,07-07-2022,07-07-2022,,,10,OPD,
10787,07-07-2022,AWOSHIE,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 7 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution | BID |  For 10 Days  ], ANTI TETANUS SERUM1500IU[ ATS | 1500IU/ML | Injection | Stat |  For 1 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DREZ SOLUTION 100ML[ DREZ  | 100ML | Solution ], ANTI TETANUS SERUM1500IU[ ATS | 1500IU/ML | Injection ]",TRADER,,07-07-2022,07-07-2022,,,65,OPD,
10804,07-07-2022,"TETEGU
CLOSE TO APOSTLEIC CHURCH",68 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 7 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",Mason,,07-07-2022,07-07-2022,,,85,OPD,
10856,07-07-2022,KOKORBITEY,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]",,TRADER,,07-07-2022,07-07-2022,,,60,OPD,
10977,07-07-2022,"DARKUMAN
NAA SIKA STREET",57 Year(s),Male,EYE CLINIC ,Consultation Adult ,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> NEW,"H35.33 [Hypertensive retinopathy, bilateral]  ==> NEW, H1131 [Conjunctival hemorrhage, right eye]  ==> NEW, I10. [Essential (primary) hypertension]  ==> NEW",No,Non-Insured,"ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | Daily |  For 30 Days  ], DICLOFENAC EYE DROP[ EPIFENAC | 10ML | Drops | TID |  For 14 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ]","ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet ], DICLOFENAC EYE DROP[ EPIFENAC | 10ML | Drops ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",driver,,07-07-2022,07-07-2022,,,60,OPD,
11175,06-07-2022,AGEGE,77 Year(s),Male,DERMATOLOGY CLINIC,Derma Review Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ]",,,06-07-2022,06-07-2022,,,10,OPD,
11185,06-07-2022,ANYAA  PALAS TOWN,80 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW, F06.4 [Organic anxiety disorder]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NAT B CAPSULES[ NAT B |  | Capsule ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,06-07-2022,06-07-2022,,,10,OPD,
11212,06-07-2022,,69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,"A01.4 [Paratyphoid fever, unspecified]  ==> NEW, M10.9 [Gout, unspecified]  ==> NEW, I82.499 [Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity]  ==> NEW, I10. [Essential (primary) hypertension]  ==> NEW, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 1 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 1 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 1 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 1 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | PRN |  For 5 Days  ]",,,,06-07-2022,06-07-2022,,,10,OPD,
11616,06-07-2022,NSAKINA,67 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,I16.0 [Hypertensive urgency]  ==> NEW,No,Non-Insured,NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ],,Unemployed,,06-07-2022,06-07-2022,,,85,OPD,
11666,06-07-2022,WENCHI ,73 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], NAT B CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ]",,,,06-07-2022,06-07-2022,,,10,OPD,
11794,06-07-2022,UPPER WEIJA ,51 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Non-Insured,"CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 14 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 14 Days  ]","CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",seamstress,,06-07-2022,06-07-2022,,,10,OPD,
11836,05-07-2022,old bortainor,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",TRADER,,05-07-2022,05-07-2022,,,10,OPD,
11838,05-07-2022,mataheko stepco junction,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, R55. [Syncope and collapse]  ==> NEW",No,Insured,,,,,05-07-2022,05-07-2022,,,20,OPD,
11840,05-07-2022,kasoa,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG |  | BID |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG |  | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG |  | Nocte |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG |  | Daily |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG |  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG |  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG |  ], METFORMIN TABLET 500MG[ DIAMET | 500MG |  ]",,,05-07-2022,05-07-2022,,,20,OPD,
11847,05-07-2022,mallam,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BDS |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,05-07-2022,05-07-2022,,,20,OPD,
11854,05-07-2022,b ortianor,21 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ]",,,,05-07-2022,05-07-2022,,,10,OPD,
11877,05-07-2022,"KASOA, OFAAKOR",69 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K29.30 [Chronic superficial gastritis without bleeding]  ==> NEW, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | Daily |  For 14 Days  ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], NUGEL - O SUSPENSION[ NUGEL - O  | 200ML | Suspension ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,05-07-2022,05-07-2022,,,10,OPD,
11882,05-07-2022,MALLAM,35 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,05-07-2022,05-07-2022,,,10,OPD,
11889,05-07-2022,"NEW BORTIANOR
LANE 2",53 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"G24.3 [Spasmodic torticollis]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> NEW, B33.0 [Epidemic myalgia]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], PREDNISOLONE TABLET 5MG[ PREDNISOLONE | 5MG | Tablet | Daily |  For 10 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], PREDNISOLONE TABLET 5MG[ PREDNISOLONE | 5MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,05-07-2022,05-07-2022,,,10,OPD,
11961,05-07-2022,Amasaman,65 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> NEW",No,Insured,,,,,05-07-2022,05-07-2022,,,10,OPD,
11970,05-07-2022,"AMASAMAN
",54 Year(s),Female,DERMATOLOGY CLINIC,Derma Review Consultation Adult ,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW",L43.0 [Hypertrophic lichen planus]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], L MONTUS ADULT 10MG[ L MONTUS ADULT | 10MG | Tablet | Nocte |  For 10 Days  ], SALICYLIC ACID OINTMENT 6%[ SALICYLIC ACID | 6% 20G | Ointment | Nocte |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], L MONTUS ADULT 10MG[ L MONTUS ADULT | 10MG | Tablet ], SALICYLIC ACID OINTMENT 6%[ SALICYLIC ACID | 6% 20G | Ointment ]",TRADER,,05-07-2022,05-07-2022,,,10,OPD,
11995,05-07-2022,OMANJOR GOVT SCH,42 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],TRADER,,05-07-2022,05-07-2022,,,25,OPD,
12092,05-07-2022,kasoa,47 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,05-07-2022,05-07-2022,,,0,OPD,
12328,05-07-2022,kasoa,55 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,05-07-2022,05-07-2022,,,0,OPD,
12406,04-07-2022,mallam,69 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 0 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 80 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 80 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 80 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 80 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,04-07-2022,04-07-2022,,,20,OPD,
12415,04-07-2022,new apleku,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 80 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 80 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 80 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 80 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ]",,,04-07-2022,04-07-2022,,,10,OPD,
12418,04-07-2022,"ABEKA
MANSTE",75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M19.91 [Primary osteoarthritis, unspecified site]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 80 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 80 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 80 Days  ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | OD |  For 80 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 80 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | PRN |  For 5 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | PRN |  For 5 Days  ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ], RENURON CAPSULE[ PREGABALIN+METHYLCOBALAMIN |  | Capsule ]",,,04-07-2022,04-07-2022,,,20,OPD,
12419,04-07-2022,WEIJA   ROMAN,47 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 80 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 80 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 80 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,04-07-2022,04-07-2022,,,10,OPD,
12434,04-07-2022,GBAWE CP,80 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, I64. [Stroke, not specified as haemorrhage or infarction]  ==> OLD",No,Insured,,,,,04-07-2022,04-07-2022,,,50,OPD,
12478,04-07-2022,WEIJA ,63 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, J18.0 [Bronchopneumonia, unspecified]  ==> NEW, K27.2 [Peptic ulcer, site unspecified: Acute with both haemorrhage and perforation]  ==> NEW, F06.4 [Organic anxiety disorder]  ==> NEW",No,Non-Insured,,,,,04-07-2022,04-07-2022,,,10,OPD,
12553,04-07-2022,weija,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,04-07-2022,04-07-2022,,,10,OPD,
12626,04-07-2022,ablekuman,62 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"I10. [Essential (primary) hypertension]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD",No,Insured,,,,,04-07-2022,04-07-2022,,,10,OPD,
12657,04-07-2022,KANESHIE,50 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,,,,,04-07-2022,04-07-2022,,,10,OPD,2966/17 MR-9A-F7-72
12687,04-07-2022,TETEGU-JUNCTN NEW SITE,69 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,"E08.29 [Diabetes mellitus due to underlying condition with other diabetic kidney complication]  ==> OLD, I10. [Essential (primary) hypertension]  ==> OLD, A20.7 [Septicaemic plague]  ==> NEW, N77.01 [Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere]  ==> NEW",No,Insured,"GENTAMICIN   INJECTION 80MG[ GENTAMICIN  | 80MG/2ML | Injection | Daily |  For 3 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet | Nocte |  For 3 Days  ], CLOTRIMAZOLE+HYDROCORTISONE CREAM[ CLOTRIMAZOLE+HYDROCOTISONE | 1%+1% 30G | Cream | BID |  For 3 Days  ]","GENTAMICIN   INJECTION 80MG[ GENTAMICIN  | 80MG/2ML | Injection ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet ], CLOTRIMAZOLE+HYDROCORTISONE CREAM[ CLOTRIMAZOLE+HYDROCOTISONE | 1%+1% 30G | Cream ]",housewife,,04-07-2022,04-07-2022,,,10,OPD,
12717,04-07-2022,gbawe bulemi,68 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 80 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 80 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 80 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 80 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",,,04-07-2022,04-07-2022,,,20,OPD,
12729,04-07-2022,ABLEKUMA PARK,59 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 5 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ]",Retired,,04-07-2022,04-07-2022,,,10,OPD,
12733,04-07-2022,GBAWE,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW, M43.6 [Torticollis]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> NEW",No,Insured,,,,,04-07-2022,04-07-2022,,,10,OPD,
13124,04-07-2022,AWOSHIE,63 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.649 [Diabetes mellitus due to underlying condition with hypoglycemia without coma]  ==> NEW,,No,Insured,"DEXTROSE INFUSION 5% 500ML[ DEXTROSE | 5% 500ML | Infusion | Daily |  For 1 Days  ], DEXTROSE INFUSION 50%[ DEXTROSE | 50% 250ML | Infusion | Stat |  For 1 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TID |  For 5 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BID |  For 1 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 21 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 5 Days  ]","DEXTROSE INFUSION 5% 500ML[ DEXTROSE | 5% 500ML | Infusion ], DEXTROSE INFUSION 50%[ DEXTROSE | 50% 250ML | Infusion ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",,,04-07-2022,04-07-2022,,,175,OPD,
13269,02-07-2022,SCC,72 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 60 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,02-07-2022,02-07-2022,,,10,OPD,
13310,02-07-2022,WHITE CROSS,53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Non-Insured,"CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], MICONAZOLE OVULE 40OMG[ MICONAZOLE PESS | 400MG | Ovule | Nocte |  For 5 Days  ]","CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], MICONAZOLE OVULE 40OMG[ MICONAZOLE PESS | 400MG | Ovule ]",TRADER,,02-07-2022,02-07-2022,,,50,OPD,
13330,02-07-2022,GBAWE,50 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E10.40 [Type 1 diabetes mellitus with diabetic neuropathy, unspecified]  ==> NEW",,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet | BDS |  For 10 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], DORETA(TRAMADOL+PARACETAMOL) TABLET[ DORETA | (37.5+500)MG | Tablet ]",Self Employed,,02-07-2022,02-07-2022,,,10,OPD,
13447,01-07-2022,AWOSHIE,61 Year(s),Female,DERMATOLOGY CLINIC,Derma Consultation Adult,,No Outcome,NA ,"E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> NEW","M79.2 [Neuralgia and neuritis, unspecified]  ==> NEW",No,Non-Insured,"NAT B CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Nocte |  For 15 Days  ]",,TRADER,,01-07-2022,01-07-2022,,,60,OPD,
13483,01-07-2022,sowutuom,47 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet | OD |  For 30 Days  ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet | OD |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 10 Days  ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet | OD |  For 10 Days  ]","NIFEDIPINE TABLET 30MG(GIT)[ NIFEDIPINE RETARD | 30MG | Tablet ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet ], ASCORBIC ACID  TABLET 100MG[ VITAMIN C | 100 | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], CETIRIZINE TABLET 10MG[ CETIRIZINE | 10MG | Tablet ]",,,01-07-2022,01-07-2022,,,10,OPD,
13562,01-07-2022,ABLEKUMA   AGAPE,76 Year(s),Male,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,"AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], PARACETAMOL TABLET 500MG[ PARACETAMOL | 500MG | Tablet | TDS |  For 7 Days  ]",,,,01-07-2022,01-07-2022,,,10,OPD,
13666,01-07-2022,AWOSHIE,52 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E13.621 [Other specified diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,"DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution | PRN |  For 5 Days  ]","DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ], DREZ SOLUTION 30ML[ DREZ  | 30ML | Solution ]",TRADER,,01-07-2022,01-07-2022,,,60,OPD,
13771,01-07-2022,ACHIASE,84 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | BDS |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Daily |  For 1 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | BID |  For 1 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ]",,,01-07-2022,01-07-2022,,,105,OPD,
13847,01-07-2022,APLAKU,58 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW,,No,Non-Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Unemployed,,01-07-2022,01-07-2022,,,85,OPD,
